Veeva Streamlines Regulatory and Quality Operations at ICON
October 18 2016 - 7:03AM
Business Wire
Veeva Vault Submissions and Veeva Vault
QualityDocs help ICON increase visibility and improve collaboration
with sponsors
2016 Veeva R&D Summit - Today at the Veeva R&D
Summit, to an audience of more than 600 industry leaders, Veeva
Systems (NYSE:VEEV) today announced that ICON, a global provider of
drug development solutions and services, is streamlining its
regulatory and quality operations with Veeva Vault applications to
increase transparency and enable greater collaboration with
sponsors.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161018005699/en/
(Graphic: Business Wire)
Veeva Vault provides ICON an integrated suite of best-in-class
applications that unify content and data for improved quality and
compliance across their global operations. Veeva Vault Submissions
delivers a single, authoritative source for ICON and their
affiliates and partners to speed the entire regulatory submission
preparation process – from authoring to assembly. Separately, Veeva
Vault QualityDocs improves GxP document management for greater
compliance, improved quality, and reduced operational overhead.
Communication, visibility, and process inefficiency are common
challenges between CROs and sponsors when data and content are
managed in multiple, disconnected systems. This hinders
collaboration and often creates duplicate work and content among
teams, introducing compliance risks that can delay time to
market.
With Veeva Vault at the heart of its regulatory and quality
operations, ICON has a single source of truth for regulatory
information and key quality policies and procedures that global
stakeholders can share in real time. Now ICON can provide its
sponsors and partners with full visibility into regulatory and
quality content for increased control and collaboration.
“Veeva Vault applications enable ICON to more easily collaborate
with sponsors on all documents throughout product development
lifecycles and streamline communications to shorten delivery
timeframes,” said Quintin van Wyk, vice president, safety,
regulatory, and writing services for ICON.
Faster, more efficient global submissions process
Vault Submissions will be part of ICON’s medical writing and
regulatory services as well as submissions management offering to
globalize their processes and make it easier to build and track
submissions content through approvals. Submission preparations are
fast and efficient, while meeting global compliance
requirements.
Improved audit readiness in quality
ICON is leveraging Vault QualityDocs to enable efficient routine
audits for its quality assurance department. The solution provides
real-time access to information, reducing compliance risk and
improving quality processes. In addition, ICON is now able to
expand its service offerings, including support for remote audits –
a service clients are requesting more often.
“Veeva Vault is a game-changer for many companies looking to
unify processes in regulatory, quality, clinical, and beyond,” said
Jennifer Goldsmith, senior vice president of Veeva Vault. “As the
level of activity between sponsors and contract services
organizations continues to increase, customers such as ICON will be
able to provide greater visibility, efficiency, and compliance for
their sponsors.”
In other news today, Veeva announced broad industry adoption of
its Veeva Vault Quality applications. Read our press release to
learn more.
Additional InformationFor more on Veeva Vault
Submissions, visit: veeva.com/SubmissionsFor more on Veeva Vault
QualityDocs, visit: veeva.com/QualityDocsConnect with Veeva on
LinkedIn: linkedin.com/company/veeva-systemsFollow us @veevasystems
on Twitter: twitter.com/veevasystemsLike Veeva on Facebook:
facebook.com/veevasystems
About Veeva SystemsVeeva Systems Inc. is a leader in
cloud-based software for the global life sciences industry.
Committed to innovation, product excellence, and customer success,
Veeva has more than 450 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in
Europe, Asia, and Latin America. For more information, visit
www.veeva.com.
Forward-looking StatementsThis release contains
forward-looking statements, including the market demand for and
acceptance of Veeva’s products and services, the results from use
of Veeva’s products and services, and general business conditions,
particularly in the life sciences industry. Any forward-looking
statements contained in this press release are based upon Veeva’s
historical performance and its current plans, estimates, and
expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this
press announcement. Subsequent events may cause these expectations
to change, and Veeva disclaims any obligation to update the
forward-looking statements in the future. These forward-looking
statements are subject to known and unknown risks and uncertainties
that may cause actual results to differ materially. Additional
risks and uncertainties that could affect Veeva’s financial results
are included under the captions, “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations,” in the company’s filing on Form 10-Q for the period
ended July 31, 2016. This is available on the company’s website at
veeva.com under the Investors section and on the SEC’s website at
sec.gov. Further information on potential risks that could affect
actual results will be included in other filings Veeva makes with
the SEC from time to time.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161018005699/en/
Veeva Systems Inc.Roger Villareal,
925-264-8885roger.villareal@veeva.comLisa Barbadora,
610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Sep 2023 to Sep 2024